PMV Pharmaceuticals, Inc.
PMVP
$1.00
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -45.98% | -15.54% | 93.04% | 20.17% | 18.55% |
| Total Depreciation and Amortization | -89.14% | 3.63% | 0.81% | 111.70% | 378.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 383.57% | -39.94% | -38.56% | -57.84% | -61.46% |
| Change in Net Operating Assets | -37.39% | 254.84% | -198.94% | -219.78% | 72.11% |
| Cash from Operations | -37.87% | -7.54% | 87.61% | -7.81% | 21.14% |
| Capital Expenditure | 71.57% | 97.73% | 99.29% | -280.77% | 87.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 416.94% | 150.87% | 103.67% | -46.27% | -109.62% |
| Cash from Investing | 399.23% | 150.89% | 103.63% | -47.29% | -111.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -40.28% | -100.00% | -93.38% | -- | -47.45% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -40.28% | -100.00% | -93.38% | -- | -47.45% |
| Foreign Exchange rate Adjustments | -132.35% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.99% | 101.76% | 101.17% | -71.29% | -269.89% |